Coastal Bridge Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Sell
56,768
-43
-0.1% -$2.47K 0.2% 112
2026
Q1
$3.45M Buy
56,811
+13,551
+31% +$790K 0.24% 96
2025
Q4
$2.33M Buy
43,260
+36,701
+560% +$1.77M 0.17% 136
2025
Q3
$296K Sell
6,559
-737
-10% -$34.4K 0.02% 367
2025
Q2
$338K Sell
7,296
-3,970
-35% -$195K 0.03% 338
2025
Q1
$687K Buy
+11,266
New +$657K 0.06% 242
2024
Q2
– Sell
-5,221
Closed -$283K – 172
2024
Q1
$283K Hold
5,221
– – 0.07% 126
2023
Q4
$268K Hold
5,221
– – 0.07% 124
2023
Q3
$303K Hold
5,221
– – 0.08% 115
2023
Q2
$334K Hold
5,221
– – 0.08% 110
2023
Q1
$362K Hold
5,221
– – 0.09% 108
2022
Q4
$376K Sell
5,221
-3,794
-42% -$286K 0.11% 101
2022
Q3
$641K Buy
9,015
+4,900
+119% +$355K 0.17% 74
2022
Q2
$317K Hold
4,115
– – 0.1% 108
2022
Q1
$301K Hold
4,115
– – 0.07% 116
2021
Q4
$257K Hold
4,115
– – 0.05% 160
2021
Q3
$243K Hold
4,115
– – 0.06% 120
2021
Q2
$275K Sell
4,115
-586
-12% -$38.2K 0.06% 117
2021
Q1
$297K Sell
4,701
-33
-0.7% -$2.05K 0.05% 104
2020
Q4
$294K Hold
4,734
– – 0.06% 103
2020
Q3
$285K Sell
4,734
-543
-10% -$32.7K 0.09% 90
2020
Q2
$310K Buy
5,277
+162
+3% +$9.69K 0.1% 94
2020
Q1
$285K Buy
5,115
+814
+19% +$49.8K 0.1% 93
2019
Q4
$276K Buy
+4,301
New +$246K 0.07% 97
2019
Q1
– Sell
-4,190
Closed -$218K – 132
2018
Q4
$218K Hold
4,190
– – 0.09% 109
2018
Q3
$260K Hold
4,190
– – 0.1% 102
2018
Q2
$232K Sell
4,190
-371
-8% -$20K 0.09% 109
2018
Q1
$288K Hold
4,561
– – 0.1% 93
2017
Q4
$280K Hold
4,561
– – 0.09% 96
2017
Q3
$291K Sell
4,561
-300
-6% -$17.5K 0.1% 84
2017
Q2
$271K Buy
4,861
+797
+20% +$43.4K 0.09% 81
2017
Q1
$221K Hold
4,064
– – 0.08% 75
2016
Q4
$238K Hold
4,064
– – 0.09% 71
2016
Q3
$219K Sell
4,064
-400
-9% -$25.7K 0.11% 55
2016
Q2
$328K Sell
4,464
-50
-1% -$3.53K 0.17% 50
2016
Q1
$288K Hold
4,514
– – 0.2% 45
2015
Q4
$311K Buy
+4,514
New +$298K 0.17% 44

Other funds holding BMY

Coastal Bridge Advisors's BMY Position: Q2 2026 in Review

Coastal Bridge Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.08% in Q2 2026, selling an estimated $2.47K and leaving 56,768 shares worth $3.27M. The position accounts for 0.2% of the portfolio, ranked #112.

Coastal Bridge Advisors first reported a position in BMY in Q4 2015 and has held it in 37 quarters since. The position peaked at $3.45M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Coastal Bridge Advisors held 56,768 shares of Bristol-Myers Squibb worth $3.27M as of Q2 2026.
  • Coastal Bridge Advisors sold 43 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.47K.
  • Bristol-Myers Squibb made up 0.2% of Coastal Bridge Advisors's portfolio in Q2 2026, its #112 holding.
  • Coastal Bridge Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 37 quarters since.
  • Coastal Bridge Advisors's Bristol-Myers Squibb position peaked at $3.45M in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.